← Leaderboards
James A Hoxie
University Of Pennsylvania
$34,253,899
Attributed
$35,409,280
Total exposure
19
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.4M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$70,644,508 · 20
By mechanism
P30$39,440,003 · 5
R01$24,441,789 · 7
R37$5,258,953 · 1
P01$890,213 · 1
R56$315,408 · 1
P51$298,142 · 5
Top collaborators
- Drew Weissman4 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Constantinos Koumenis$17,144,115
- Joseph G Sodroski$53,351,794
- Kelly L Jordan-Sciutto$26,892,677
- Wenchao Song$30,516,555
- Allan Ian Pack$56,782,953
Others in their field
Top investigators on “Vaccines”
- Lawrence Corey · Fred Hutchinson Cancer Center$829,044,908
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$556,540,832
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$515,215,260
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
- Dennis R. Burton · Scripps Research Institute$316,106,418
Research focus
VaccinesPathogenesisViralBaseImmune ResponseAcquired Immunodeficiency SyndromeVirusCellsImmuneHiv-1InfectionMutationStructureCd4 Positive T LymphocytesNonhuman PrimateIn VivoNeutralizing AntibodyAnimalsInsightProgramsCytoplasmic TailResearch PersonnelEventSignal Transduction
Grant awards (85)
Targeted interventions to reduce or eliminate the SIV reservoir in a novel model of elite control$665,106
R01 · FY2025 · AI · contact PI
Targeted interventions to reduce or eliminate the SIV reservoir in a novel model of elite control$675,959
R01 · FY2024 · AI · contact PI
Targeted interventions to reduce or eliminate the SIV reservoir in a novel model of elite control$787,676
R01 · FY2023 · AI · contact PI
Targeted interventions to reduce or eliminate the SIV reservoir in a novel model of elite control$770,741
R01 · FY2021 · AI · contact PI
Role of SIV and HIV Env cytoplasmic tail in pathogenesis and protective immunity$761,861
R01 · FY2021 · AI · contact PI
Targeted interventions to reduce or eliminate the SIV reservoir in a novel model of elite control$850,199
R01 · FY2020 · AI · contact PI
Role of SIV and HIV Env cytoplasmic tail in pathogenesis and protective immunity$752,353
R01 · FY2020 · AI · contact PI
Role of SIV and HIV Env cytoplasmic tail in pathogenesis and protective immunity$782,237
R01 · FY2019 · AI · contact PI
Role of SIV and HIV Env cytoplasmic tail in pathogenesis and protective immunity$805,483
R01 · FY2018 · AI · contact PI
Administrative Core$328,130
P30 · FY2018 · AI · contact PI
Non-CD4 tropic SIV: Enhancing CD4 T-cell help in antiviral immune responses$808,787
R01 · FY2017 · AI · contact PI
Administrative Core$377,454
P30 · FY2017 · AI · contact PI
Non-CD4 tropic SIV: Enhancing CD4 T-cell help in antiviral immune responses$816,112
R01 · FY2016 · AI · contact PI
Administrative Core$344,871
P30 · FY2016 · AI · contact PI
Non-CD4 tropic SIV: Enhancing CD4 T-cell help in antiviral immune responses$818,896
R01 · FY2015 · AI · contact PI
Pathogenic determinants of the SIV envelope transmembrane cytoplasmic domain$795,242
R01 · FY2015 · AI · contact PI
Administrative Core$332,189
P30 · FY2015 · AI · contact PI
Center for AIDS Research$2,952,749
P30 · FY2014 · AI · contact PI
Non-CD4 tropic SIV: Enhancing CD4 T-cell help in antiviral immune responses$842,308
R01 · FY2014 · AI · contact PI
Pathogenic determinants of the SIV envelope transmembrane cytoplasmic domain$778,218
R01 · FY2014 · AI · contact PI
Administrative Core$353,051
P30 · FY2014 · AI · contact PI
Center for AIDS Research$2,444,880
P30 · FY2013 · AI · contact PI
Pathogenic determinants of the SIV envelope transmembrane cytoplasmic domain$951,507
R01 · FY2013 · AI · contact PI
Modified HIV Evns for structure function & vaccine studies$535,910
R37 · FY2013 · AI · contact PI
Optimizing HIV Env immuogens for T and B cell vaccine responses$517,685
R01 · FY2013 · AI
Administrative$282,341
P30 · FY2013 · AI · contact PI
Center for AIDS Research$3,047,509
P30 · FY2012 · AI · contact PI
Pathogenic determinants of the SIV envelope transmembrane cytoplasmic domain$813,747
R01 · FY2012 · AI · contact PI
Modified HIV Evns for structure function & vaccine studies$570,117
R37 · FY2012 · AI · contact PI
Optimizing HIV Env immuogens for T and B cell vaccine responses$551,934
R01 · FY2012 · AI
Administrative$376,887
P30 · FY2012 · AI · contact PI
Center for AIDS Research$2,916,583
P30 · FY2011 · AI · contact PI
Pathogenic determinants of the SIV envelope transmembrane cytoplasmic domain$830,518
R01 · FY2011 · AI · contact PI
Optimizing HIV Env immuogens for T and B cell vaccine responses$654,103
R01 · FY2011 · AI
Modified HIV Evns for structure function & vaccine studies$558,565
R37 · FY2011 · AI · contact PI
Administrative$335,587
P30 · FY2011 · AI · contact PI
CONTROL OF AN SIVMAC239 TRANSMEMBRANE MUTANT IN PIGTAIL MACAQUES$57,750
P51 · FY2011 · RR · contact PI
PATHOGENESIS OF AN ATTENUATED SIVMAC239 IN RHESUS AND PIGTAIL MACAQUES$57,750
P51 · FY2011 · RR · contact PI
Center for AIDS Research$2,877,209
P30 · FY2010 · AI · contact PI
Pathogenic determinants of the SIV envelope transmembrane cytoplasmic domain$598,754
R01 · FY2010 · AI · contact PI
Optimizing HIV Env immuogens for T and B cell vaccine responses$587,041
R01 · FY2010 · AI
Modified HIV Evns for structure function & vaccine studies$564,130
R37 · FY2010 · AI · contact PI
Administrative$331,064
P30 · FY2010 · AI · contact PI
PATHOGENIC DETERMINANTS OF THE SIV ENVELOPE TRANSMEMBRANE CYTOPLASMIC DOMAIN$61,801
P51 · FY2010 · RR · contact PI
Center for AIDS Research$2,825,695
P30 · FY2009 · AI · contact PI
Pathogenic determinants of the SIV envelope transmembrane cytoplasmic domain$941,644
R01 · FY2009 · AI · contact PI
Modified HIV Evns for structure function & vaccine studies$549,938
R37 · FY2009 · AI · contact PI
Administrative$294,717
P30 · FY2009 · AI · contact PI
Pilot Projects$246,700
P30 · FY2009 · AI · contact PI
PATHOGENIC DETERMINANTS OF THE SIV ENVELOPE TRANSMEMBRANE CYTOPLASMIC DOMAIN$62,692
P51 · FY2009 · RR · contact PI
PATHOGENESIS OF AN X4-TROPIC VARIANT OF SIVMAC239$58,149
P51 · FY2009 · RR · contact PI
Center For AIDS Research$2,500,675
P30 · FY2008 · AI · contact PI
Pathogenic determinants of the SIV envelope transmembrane cytoplasmic domain$643,694
R01 · FY2008 · AI · contact PI
Modified HIV Envs: structure, function & vaccine studies$520,557
R37 · FY2008 · AI · contact PI
Administrative Core$259,619
P30 · FY2008 · AI · contact PI
Center For AIDS Research$2,956,316
P30 · FY2007 · AI · contact PI
Modified HIV Envs: structure, function & vaccine studies$516,468
R37 · FY2007 · AI · contact PI
Administrative$342,165
P30 · FY2007 · AI · contact PI
Pathogenic determinants in the SIV envelope transmembrane cytoplasmic domain$315,408
R56 · FY2007 · AI · contact PI
Hybridoma Core$117,212
P01 · FY2007 · HL · contact PI
Center For AIDS Research$2,540,136
P30 · FY2006 · AI · contact PI
Modified HIV Envs: structure, function & vaccine studies$517,725
R37 · FY2006 · AI · contact PI
Pathogenic Determinants of SIV Envelope Glycoproteins$70,825
R01 · FY2006 · AI · contact PI
Center For AIDS Research$2,338,399
P30 · FY2005 · AI
Pathogenic Determinants of SIV Envelope Glycoproteins$750,190
R01 · FY2005 · AI
Modified HIV Envs: structure, function &vaccine studies$469,610
R37 · FY2005 · AI
Center For AIDS Research$2,249,901
P30 · FY2004 · AI
Pathogenic Determinants of SIV Envelope Glycoproteins$778,978
R01 · FY2004 · AI
Modified HIV Envs: structure, function &vaccine studies$455,933
R37 · FY2004 · AI
CENTER FOR AIDS RESEARCH$1,425,153
P30 · FY2003 · AI
Pathogenic Determinants of SIV Envelope Glycoproteins$758,178
R01 · FY2003 · AI
EVALUATION OF CD4 INDEPENDENT HIV AND SIV ENV PROTEINS$466,665
R01 · FY2003 · AI
Hybridoma Core$72,289
P01 · FY2003 · HL
CENTER FOR AIDS RESEARCH$1,388,925
P30 · FY2002 · AI
Pathogenic Determinants of SIV Envelope Glycoproteins$748,850
R01 · FY2002 · AI
EVALUATION OF CD4 INDEPENDENT HIV AND SIV ENV PROTEINS$455,587
R01 · FY2002 · AI
CORE--HYBRIDOMA$197,196
P01 · FY2002 · HL
CENTER FOR AIDS RESEARCH$1,353,748
P30 · FY2001 · AI
Pathogenic Determinants of SIV Envelope Glycoproteins$737,476
R01 · FY2001 · AI
EVALUATION OF CD4 INDEPENDENT HIV AND SIV ENV PROTEINS$443,070
R01 · FY2001 · AI
CORE--HYBRIDOMA$197,196
P01 · FY2001 · HL
CENTER FOR AIDS RESEARCH$92,109
P30 · FY2001 · AI
CENTER FOR AIDS RESEARCH$1,325,241
P30 · FY2000 · AI
EVALUATION OF CD4 INDEPENDENT HIV AND SIV ENV PROTEINS$430,165
R01 · FY2000 · AI
CORE--HYBRIDOMA$306,320
P01 · FY2000 · HL